JSPR Insider Trading

Insider Ownership Percentage: 2.70%
Insider Buying (Last 12 Months): $4,532,500.00
Insider Selling (Last 12 Months): $64,647.00

Jasper Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Jasper Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Jasper Therapeutics Share Price & Price History

Current Price: $20.98
Price Change: Price Increase of +0.29 (1.40%)
As of 11/20/2024 01:00 AM ET

This chart shows the closing price history over time for JSPR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Jasper Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/12/2024Jeetinder Singh MahalCOOSell900$21.23$19,107.0025,009View SEC Filing Icon  
6/12/2024Jeetinder Singh MahalCOOSell900$24.16$21,744.0025,009View SEC Filing Icon  
3/12/2024Jeetinder Singh MahalCOOSell900$26.44$23,796.0025,009View SEC Filing Icon  
2/8/2024Velan Capital Investment ManagMajor ShareholderBuy350,000$12.95$4,532,500.001,188,500View SEC Filing Icon  
11/20/2023Thomas G WiggansDirectorBuy1,000$6.30$6,300.003,000View SEC Filing Icon  
11/16/2023Thomas G WiggansDirectorBuy1,000$6.00$6,000.001,000View SEC Filing Icon  
10/13/2023William LisDirectorSell796$8.50$6,766.005,352View SEC Filing Icon  
6/13/2023Jeetinder Singh MahalInsiderSell900$16.60$14,940.0028,722View SEC Filing Icon  
4/14/2023Anna Louise FrenchDirectorSell700$14.80$10,360.002,375View SEC Filing Icon  
1/27/2023Carlyle Group Inc.Major ShareholderBuy313,333$15.00$4,699,995.00876,189View SEC Filing Icon  
1/25/2023Holding Ltd RocheMajor ShareholderSell7,500$18.90$141,750.00454,960View SEC Filing Icon  
6/27/2022William LisDirectorSell2,474$20.80$51,459.204,048View SEC Filing Icon  
6/24/2022William LisDirectorSell2,474$20.20$49,974.806,522View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Jasper Therapeutics (NASDAQ:JSPR)

79.85% of Jasper Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at JSPR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Jasper Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC16,146$0.30M0.0%+320.7%0.108%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC257,416$4.84M0.0%-0.9%1.704%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC16,146$0.30M0.0%+320.7%0.107%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC13,354$0.25M0.0%N/A0.088%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP23,759$0.45M0.0%N/A0.157%Search for SEC Filing on Google Icon
11/15/2024State Street Corp214,883$4.04M0.0%+12.3%1.423%Search for SEC Filing on Google Icon
11/15/2024Samsara BioCapital LLC584,642$11M2.1%+11.4%3.872%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC55,175$1.04M0.1%-47.5%0.365%Search for SEC Filing on Google Icon
11/14/2024Braidwell LP483,300$9.09M0.3%N/A3.201%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC25,353$0.48M0.0%N/A0.168%Search for SEC Filing on Google Icon
11/14/2024Ally Bridge Group NY LLC399,466$7.51M4.0%+82.7%2.645%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC6,874$0.13M0.0%+129.1%0.046%Search for SEC Filing on Google Icon
11/13/2024Great Point Partners LLC322,380$6.06M1.8%-19.8%2.135%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets2,512$47K0.0%+208.6%0.017%Search for SEC Filing on Google Icon
11/13/2024FMR LLC38,361$0.72M0.0%N/A0.254%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC17,500$0.33M0.2%N/A0.116%Search for SEC Filing on Google Icon
10/29/2024Fernwood Investment Management LLC52,897$1M0.3%+6.9%0.351%Search for SEC Filing on Google Icon
10/16/2024Wolff Wiese Magana LLC3,146$59K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/14/2024Great Point Partners LLC402,015$9.13M1.7%-1.4%2.669%Search for SEC Filing on Google Icon
8/14/2024Ally Bridge Group NY LLC218,614$4.96M3.0%-24.6%1.451%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.14,204$0.32M0.0%+27.1%0.094%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers13,231$0.30M0.0%N/A0.088%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp32,579$0.74M0.0%N/A0.216%Search for SEC Filing on Google Icon
5/29/2024Opaleye Management Inc.435,573$12.79M2.8%-89.1%2.892%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC10,410$0.31M0.0%N/A0.069%Search for SEC Filing on Google Icon
5/17/2024Ikarian Capital LLC105,175$3.09M0.3%N/A0.698%Search for SEC Filing on Google Icon
5/16/2024Kingdon Capital Management L.L.C.497,000$14.59M1.6%-86.0%3.300%Search for SEC Filing on Google Icon
5/14/2024Qiming U.S. Ventures Management LLC928,964$27.27M30.4%-89.1%6.168%Search for SEC Filing on Google Icon
5/14/2024StemPoint Capital LP129,211$3.79M1.0%N/A0.858%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.612,745$17.99M0.0%-85.0%4.069%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.79,811$2.34M0.0%N/A0.530%Search for SEC Filing on Google Icon
5/7/2024Concurrent Investment Advisors LLC20,409$0.60M0.0%N/A0.136%Search for SEC Filing on Google Icon
5/3/2024Carlyle Group Inc.1,066,189$31.30M2.0%-87.8%7.080%Search for SEC Filing on Google Icon
3/18/2024Kingdon Capital Management L.L.C.3,540,000$2.79M0.3%+16.4%31.720%Search for SEC Filing on Google Icon
2/15/2024Opaleye Management Inc.3,985,340$3.14M0.8%N/A35.717%Search for SEC Filing on Google Icon
2/7/2024Ieq Capital LLC54,500$43K0.0%N/A0.488%Search for SEC Filing on Google Icon
2/7/2024Monaco Asset Management SAM249,563$0.20M0.1%N/A2.236%Search for SEC Filing on Google Icon
2/5/2024Fernwood Investment Management LLC494,706$0.39M0.1%+8.8%4.433%Search for SEC Filing on Google Icon
11/13/2023Mariner LLC652,749$0.46M0.0%-8.7%0.589%Search for SEC Filing on Google Icon
11/9/2023Cowen AND Company LLC200,393$0.14M0.0%N/A0.181%Search for SEC Filing on Google Icon
11/8/2023Forefront Analytics LLC110,792$78K0.0%+59.7%0.100%Search for SEC Filing on Google Icon
10/30/2023Summit Trail Advisors LLC65,000$46K0.0%N/A0.059%Search for SEC Filing on Google Icon
8/15/2023Sphera Funds Management LTD.4,274,008$5.86M0.9%+5.7%3.874%Search for SEC Filing on Google Icon
8/14/2023Jefferies Financial Group Inc.489,884$0.67M0.0%N/A0.444%Search for SEC Filing on Google Icon
6/1/2023Prelude Capital Management LLC54,500$99K0.0%N/A0.049%Search for SEC Filing on Google Icon
5/16/2023Ally Bridge Group NY LLC2,517,232$4.56M6.0%N/A2.301%Search for SEC Filing on Google Icon
5/16/2023BVF Inc. IL9,900,000$17.92M0.7%N/A9.051%Search for SEC Filing on Google Icon
5/15/2023Affinity Asset Advisors LLC476,948$0.86M0.3%N/A0.436%Search for SEC Filing on Google Icon
5/15/2023Kingdon Capital Management L.L.C.3,040,000$5.50M1.0%+463.0%2.779%Search for SEC Filing on Google Icon
5/15/2023RTW Investments LP2,329,809$4.22M0.1%N/A2.130%Search for SEC Filing on Google Icon
5/12/2023Forefront Analytics LLC30,290$55K0.0%-73.4%0.028%Search for SEC Filing on Google Icon
5/5/2023Carlyle Group Inc.8,761,891$15.77M0.5%N/A8.011%Search for SEC Filing on Google Icon
5/3/2023Jump Financial LLC33,074$60K0.0%N/A0.030%Search for SEC Filing on Google Icon
4/25/2023Qiming U.S. Ventures Management LLC8,519,648$15.42M18.7%+45.6%7.789%Search for SEC Filing on Google Icon
2/13/2023Forefront Analytics LLC114,000$55K0.0%-4.8%0.300%Search for SEC Filing on Google Icon
2/7/2023Fernwood Investment Management LLC454,706$0.22M0.1%+53.1%1.197%Search for SEC Filing on Google Icon
11/14/2022Forefront Analytics LLC119,800$94K0.1%+246.0%0.327%Search for SEC Filing on Google Icon
11/9/2022Fernwood Investment Management LLC297,080$0.23M0.1%N/A0.810%Search for SEC Filing on Google Icon
5/10/2022Sectoral Asset Management Inc.675,000$2.40M0.4%N/A1.782%Search for SEC Filing on Google Icon
5/9/2022Forefront Analytics LLC32,550$0.12M0.0%N/A0.086%Search for SEC Filing on Google Icon
4/27/2022Vahanian & Associates Financial Planning Inc.10,000$36K0.1%-60.0%0.026%Search for SEC Filing on Google Icon
2/15/2022Kingdon Capital Management L.L.C.540,000$4.24M0.5%N/A1.427%Search for SEC Filing on Google Icon
2/2/2022Grace Capital218,110$1.71M1.0%N/A0.576%Search for SEC Filing on Google Icon
1/28/2022Vahanian & Associates Financial Planning Inc.25,000$0.20M0.2%N/A0.066%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC3,005,035$29.22M0.0%N/A8.228%Search for SEC Filing on Google Icon
11/15/2021Tudor Investment Corp Et Al20,000$0.21M0.0%N/A0.055%Search for SEC Filing on Google Icon
11/15/2021Abingworth LLP5,628,558$58.03M13.2%N/A15.412%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Jasper Therapeutics logo
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and conditioning regimens for stem cell transplantation. In addition, it is also developing stem cell transplants for rare diseases such as sickle cell disease, fanconi anemia, chronic granulomatous diseases, and GATA2 MDS, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.
Read More on Jasper Therapeutics

Today's Range

Now: $20.98
Low: $19.79
High: $21.00

50 Day Range

MA: $20.28
Low: $14.72
High: $24.73

52 Week Range

Now: $20.98
Low: $4.00
High: $31.01

Volume

216,680 shs

Average Volume

263,832 shs

Market Capitalization

$314.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.19

Who are the company insiders with the largest holdings of Jasper Therapeutics?

Jasper Therapeutics' top insider investors include:
  1. Velan Capital Investment Manag (Major Shareholder)
  2. Carlyle Group Inc (Major Shareholder)
  3. Holding Ltd Roche (Major Shareholder)
  4. Jeetinder Singh Mahal (Insider)
  5. Jeetinder Singh Mahal (COO)
  6. William Lis (Director)
  7. Thomas G Wiggans (Director)
  8. Anna Louise French (Director)
Learn More about top insider investors at Jasper Therapeutics.

Who are the major institutional investors of Jasper Therapeutics?

Jasper Therapeutics' top institutional shareholders include:
  1. Samsara BioCapital LLC — 3.87%
  2. Braidwell LP — 3.20%
  3. Ally Bridge Group NY LLC — 2.65%
  4. Great Point Partners LLC — 2.13%
  5. Geode Capital Management LLC — 1.70%
  6. State Street Corp — 1.42%
Learn More about top institutional investors of Jasper Therapeutics stock.

Which institutional investors are selling Jasper Therapeutics stock?

During the last quarter, JSPR stock was sold by these institutional investors:
  1. Great Point Partners LLC
  2. Ikarian Capital LLC
  3. Geode Capital Management LLC

Which institutional investors are buying Jasper Therapeutics stock?

During the previous quarter, JSPR stock was acquired by institutional investors including:
  1. Braidwell LP
  2. Ally Bridge Group NY LLC
  3. Samsara BioCapital LLC
  4. FMR LLC
  5. Verition Fund Management LLC
  6. Wellington Management Group LLP
  7. State Street Corp
  8. AlphaCentric Advisors LLC
Within the previous year, these company insiders have bought Jasper Therapeutics stock:
  1. Velan Capital Investment Manag (Major Shareholder)
  2. Carlyle Group Inc (Major Shareholder)
  3. Holding Ltd Roche (Major Shareholder)
Learn More investors buying Jasper Therapeutics stock.